SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-14-000307
Filing Date
2014-05-12
Accepted
2014-05-12 16:17:03
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED 3/31/2014 appy_10q-033114.htm 10-Q 559109
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 12460
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 12257
4 EXHIBIT 32 ex32.htm EX-32 9109
  Complete submission text file 0001079973-14-000307.txt   4362143

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE appy-20140331.xml EX-101.INS 557701
6 XBRL SCHEMA FILE appy-20140331.xsd EX-101.SCH 32407
7 XBRL CALCULATION FILE appy-20140331_cal.xml EX-101.CAL 41137
8 XBRL DEFINITION FILE appy-20140331_def.xml EX-101.DEF 132229
9 XBRL LABEL FILE appy-20140331_lab.xml EX-101.LAB 503598
10 XBRL PRESENTATION FILE appy-20140331_pre.xml EX-101.PRE 248192
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 14833612
SIC: 2835 In Vitro & In Vivo Diagnostic Substances